CCNE1 Amplification and Overexpression Characterizes Ovarian Clear Cell Carcinoma But Not Ovarian Endometrioid Carcinoma

被引：0
|
作者：
Ayhan, Ayse
Ogawa, Hiroshi
Bahadirli-Talbott, Asli
Wu, Ren-Chin
Sugimura, Haruhiko
Wang, Tian-Li
Shih, Ie-Ming
机构：
[1] Johns Hopkins Med Inst, Baltimore, MD 21205 USA
[2] Seirei Mikatahara Hosp, Hamamatsu, Shizuoka, Japan
[3] Chang Gung Mem Hosp, Taoyuan, Taiwan
[4] Chang Gung Univ, Coll Med, Taoyuan, Taiwan
[5] Hamamatsu Univ Sch Med, Hamamatsu, Shizuoka 4313192, Japan
来源：
MODERN PATHOLOGY | 2015年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
1092
引用
收藏
页码：273A / 274A
页数：2
相关论文
共 50 条
  • [21] Ovarian endometrioid carcinoma and clear cell carcinoma: A 21-year retrospective study
    Zhou, Ling
    Yao, Liqing
    Dai, Lin
    Zhu, Honglan
    Ye, Xue
    Wang, Shang
    Cheng, Hongyan
    Ma, Ruiqiong
    Liu, Huiping
    Cui, Heng
    Chang, Xiaohong
    JOURNAL OF OVARIAN RESEARCH, 2021, 14 (01)
  • [22] CCNE1 Amplification as a Predictive Biomarker of Chemotherapy Resistance in Epithelial Ovarian Cancer
    Gorski, Justin W.
    Ueland, Frederick R.
    Kolesar, Jill M.
    DIAGNOSTICS, 2020, 10 (05)
  • [23] CCNE1 Amplification May Precede Centrosome Number Abnormality in Progression from Serous Tuba! Intraepithelial Carcinoma to High-Grade Ovarian Serous Carcinoma
    Kuhn, E.
    Bahadirli-Talbott, A.
    Kurman, R.
    Sehdev, A. S.
    Wang, T-L
    Shih, I-M
    LABORATORY INVESTIGATION, 2013, 93 : 283A - 283A
  • [24] CCNE1 Amplification May Precede Centrosome Number Abnormality in Progression from Serous Tubal Intraepithelial Carcinoma to High-Grade Ovarian Serous Carcinoma
    Kuhn, E.
    Bahadirli-Talbott, A.
    Kurman, R.
    Sehdev, A. S.
    Wang, T-L
    Shih, I-M
    MODERN PATHOLOGY, 2013, 26 : 283A - 283A
  • [25] Histo-genomic stratification reveals the frequent amplification/overexpression of CCNE1 and BRD4 genes in non-BRCAness high grade ovarian carcinoma
    Goundiam, Oumou
    Gestraud, Pierre
    Popova, Tatiana
    Rouge, Thibault De la Motte
    Fourchotte, Virginie
    Gentien, David
    Hupe, Philippe
    Becette, Veronique
    Houdayer, Claude
    Roman-Roman, Sergio
    Stern, Marc-Henri
    Sastre-Garau, Xavier
    INTERNATIONAL JOURNAL OF CANCER, 2015, 137 (08) : 1890 - 1900
  • [26] Ethnic variations in ARID1 a expression in clear cell and endometrioid ovarian carcinoma.
    Lai, Tiffany
    Vierkoetter, Koah
    Ayabe, Asia
    Ahn, Hyeong Jun
    Shimizu, David
    Terada, Keith Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] The effect of concurrent endometriosis on the prognosis of women with ovarian clear cell or endometrioid carcinoma
    Ju, U. Chul
    Kang, Woo Dae
    Kim, Seok Mo
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2019, 146 (02) : 177 - 183
  • [28] Clear cell/endometrioid type ovarian carcinoma associated with endometriosis of the ipsilateral ovary
    Biljic-Erski, Ivana Rudic
    Vasiljevic, Mladenko
    Rakic, Snezana
    Dzatic-Smiljkovic, Olivera
    Mihajlovic, Sladjana
    VOJNOSANITETSKI PREGLED, 2019, 76 (05) : 547 - 551
  • [29] CCNE1 amplification is associated with aggressive potential in endometrioid endometrial carcinomas
    Nakayama, Kentaro
    Rahman, Mohamed Tanjimur
    Rahman, Munmun
    Nakamura, Kohei
    Ishikawa, Masako
    Katagiri, Hiroshi
    Sato, Emi
    Ishibashi, Tomoka
    Iida, Kouji
    Ishikawa, Noriyuki
    Kyo, Satoru
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2016, 48 (02) : 506 - 516
  • [30] The presence of clear cell glands around the ovarian endometrioid cyst has an association with clear cell carcinoma
    Qu, Jiani
    Yu, Jing
    Zhong, Siyuan
    Wang, Wenchao
    Wang, Qingping
    Du, Bin
    VIRCHOWS ARCHIV, 2023, 482 (06) : 1021 - 1034
12345